JPH11269175A - A novel ultraviolet absorbing substance produced by marine bacteria and its production method - Google Patents
A novel ultraviolet absorbing substance produced by marine bacteria and its production methodInfo
- Publication number
- JPH11269175A JPH11269175A JP9385598A JP9385598A JPH11269175A JP H11269175 A JPH11269175 A JP H11269175A JP 9385598 A JP9385598 A JP 9385598A JP 9385598 A JP9385598 A JP 9385598A JP H11269175 A JPH11269175 A JP H11269175A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- culture
- present
- ultraviolet absorbing
- absorbing substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 241000894006 Bacteria Species 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 41
- 244000005700 microbiome Species 0.000 claims abstract description 9
- 241001057811 Paracoccus <mealybug> Species 0.000 claims description 6
- 239000006097 ultraviolet radiation absorber Substances 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 21
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- 241000589598 Paracoccus sp. Species 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000006325 marine broth Substances 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000006327 marine agar Substances 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- CSCPPACGZOOCGX-WFGJKAKNSA-N deuterated acetone Substances [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102220201851 rs143406017 Human genes 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical class COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009633 stab culture Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
(57)【要約】
【課題】 紫外線吸収剤として有用な物質を提供する。
【解決手段】 下記の式(I)、(II)または(II
I)
で表される化合物であって、脂溶性の紫外線吸収物質で
ある。該化合物は微生物を用いて製造する。(57) [Problem] To provide a substance useful as an ultraviolet absorber. SOLUTION: The following formula (I), (II) or (II)
I) Which is a fat-soluble ultraviolet absorbing substance. The compound is produced using a microorganism.
Description
【0001】[0001]
【発明の属する技術分野】本発明は、紫外線吸収物質と
して有用な新規化合物、および微生物を用いたその製造
法に関する。[0001] The present invention relates to a novel compound useful as an ultraviolet absorbing material, and a method for producing the same using a microorganism.
【0002】[0002]
【従来の技術】従来、化粧品などには紫外線吸収剤とし
てベンゾフェノン誘導体、パラアミノ安息香酸誘導体、
パラメトキシ桂皮酸誘導体、サリチル酸誘導体などの化
学合成品が主に使用されてきた。しかし、化学合成品に
対する拒否反応も伴って、天然物の中から安全性が高い
新規紫外線吸収物質を探索し、それを応用、利用しよう
とする研究が行われている。天然の紫外線吸収物質とし
ては、例えば、ボータニカマリーナ(Bot.Ma
r.)vol.16,No.23(1974)、マリー
ンバイオロジー(Mar.Biol.)vol.10
8,No.157(1991)、ジャーナルオブプラン
クトンリサーチ(J.Plankton Res.)v
ol.12,No.909(1990)、プラントデイ
ジーズレポーター(Plant Dis.Rept
r.)vol.57,No.760(1973)に開示
されているように、海藻、海底動物、微細藻、カビ類な
どが生産するマイコスポリン様アミノ酸類が知られてい
る。2. Description of the Related Art Conventionally, benzophenone derivatives, paraaminobenzoic acid derivatives,
Chemically synthesized products such as paramethoxycinnamic acid derivatives and salicylic acid derivatives have been mainly used. However, with the rejection of chemically synthesized products, research is being conducted to search for novel UV-absorbing substances having high safety from natural products, and to apply and utilize them. As a natural ultraviolet absorbing substance, for example, Botanica Marina (Bot. Ma)
r. ) Vol. 16, No. 23 (1974), Marine Biology (Mar. Biol.) Vol. 10
8, No. 157 (1991), Journal of Plankton Research (J. Plankton Res.) V
ol. 12, No. 909 (1990), Plant Daisies Reporter (Plant Dis. Rept)
r. ) Vol. 57, no. As disclosed in 760 (1973), mycosporin-like amino acids produced by seaweeds, marine animals, microalgae, molds and the like are known.
【0003】[0003]
【発明が解決しようとする課題】しかしながらこれらの
物質は水溶性であるためその応用範囲が限られている。
このため、天然物に由来し、脂溶性の紫外線吸収物質が
求められていた。However, since these substances are water-soluble, their application range is limited.
For this reason, a fat-soluble ultraviolet absorbing substance derived from a natural product has been demanded.
【0004】本発明は、かかる技術的背景の下になされ
たものであり、その目的は、天然物に由来し、脂溶性の
新規な紫外線吸収物質およびその製造方法を提供するこ
とにある。The present invention has been made under such a technical background, and an object of the present invention is to provide a novel fat-soluble ultraviolet absorbing substance derived from a natural product and a method for producing the same.
【0005】[0005]
【発明を解決するための手段】本発明者は、パラコッカ
ス属に属する菌株の培養液から得られた化合物が、従来
まったく知られていない新規な化合物であることを見出
し、本発明を完成した。Means for Solving the Problems The present inventors have found that a compound obtained from a culture of a strain belonging to the genus Paracoccus is a novel compound that has never been known before, and completed the present invention.
【0006】即ち、本発明は、下記の式(I)、(I
I)又は(III)That is, the present invention provides the following formulas (I) and (I)
I) or (III)
【0007】[0007]
【化4】 Embedded image
【0008】[0008]
【化5】 Embedded image
【0009】[0009]
【化6】 で表わされる化合物である。Embedded image It is a compound represented by these.
【0010】また、本発明は、パラコッカス属に属し、
上記記載の化合物を生産する能力を有する微生物を培地
に培養し、培養物中に上記記載の化合物を生成蓄積さ
せ、該培養物から上記記載の化合物を採取することを特
徴とする上記記載の化合物の製造法である。[0010] The present invention also belongs to the genus Paracoccus,
A microorganism having the ability to produce the compound described above is cultured in a medium, the compound described above is produced and accumulated in a culture, and the compound described above is collected from the culture. It is a manufacturing method of.
【0011】[0011]
【発明の実施の形態】以下に本発明を詳細に説明する。DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail.
【0012】(1) 本発明の化合物の性質 本発明の一群の新規な化合物は、下記の式(I)、(I
I)又は(III)で表わされる。(1) Properties of the compounds of the present invention A group of novel compounds of the present invention is represented by the following formulas (I) and (I)
It is represented by I) or (III).
【0013】[0013]
【化7】 Embedded image
【0014】[0014]
【化8】 Embedded image
【0015】[0015]
【化9】 式(I)で表される化合物の理化学的性状を以下に示
す。 (1) 物質の色:赤茶 (2) 分子量:230 (3) 分子式:C12H10N2OS (4) 質量分析:高分解FABMS、実測値 23
1.0606 M+H+、計算値 231.0592
(C12H11N2OS) (5) 紫外線吸収スペクトル (アセトニトリル中):λmax 210nm(ε133
00)、258nm(3400)、269nm(320
0)、275nm(3100)、320nm(230
0) (6) 赤外線吸収スペクトル (KBr) νmax 3266、1605、1520、1448、1
435、1050、806、750 cm-1 (7) 1H−NMR(重アセトン中で測定、500M
Hz) δppm 3.34(t,2H,J=8.7Hz)、
4.62(t,2H,J=8.7Hz)、7.27
(m,2H)、7.55(m,2H)、8.36(m,
1H)、8.80(s,1H)、11.1(s,NH) (8) 13C−NMR(重アセトン中で測定、125M
Hz) δppm 32.4(t)、68.1(t)、113.
6(d)、115.1(s)、123.3(d)、12
3.9(d)、124.9(d)、128.2(s)、
138.1(s)、128.9(d)、172.9
(s)、181.0(s) (9) 溶解性:DMSO、アセトニトリル、メタノー
ル、エタノール、アセトン、酢酸エチルおよびクロロホ
ルムに可溶、水には難溶。Embedded image The physicochemical properties of the compound represented by the formula (I) are shown below. (1) Color of substance: reddish brown (2) Molecular weight: 230 (3) Molecular formula: C 12 H 10 N 2 OS (4) Mass spectrometry: High-resolution FABMS, measured value 23
1.0606 M + H + , calculated 231.0592
(C 12 H 11 N 2 OS) (5) Ultraviolet absorption spectrum (in acetonitrile): λ max 210 nm (ε 133
00), 258 nm (3400), 269 nm (320
0), 275 nm (3100), 320 nm (230
0) (6) Infrared absorption spectrum (KBr) ν max 3266, 1605, 1520, 1448, 1
435, 1050, 806, 750 cm -1 (7) 1 H-NMR (measured in deuterated acetone, 500 M
Hz) δ ppm 3.34 (t, 2H, J = 8.7 Hz),
4.62 (t, 2H, J = 8.7 Hz), 7.27
(M, 2H), 7.55 (m, 2H), 8.36 (m, 2H)
1H), 8.80 (s, 1H), 11.1 (s, NH) (8) 13 C-NMR (measured in deuterated acetone, 125 M
Hz) δ ppm 32.4 (t), 68.1 (t), 113.
6 (d), 115.1 (s), 123.3 (d), 12
3.9 (d), 124.9 (d), 128.2 (s),
138.1 (s), 128.9 (d), 172.9
(S), 181.0 (s) (9) Solubility: Soluble in DMSO, acetonitrile, methanol, ethanol, acetone, ethyl acetate and chloroform, poorly soluble in water.
【0016】式(II)で表される化合物の理化学的性
状を以下に示す。 (1) 物質の色:無色 (2) 分子量:314 (3) 分子式:C20H14N2O2 (4) 質量分析:高分解FABMS、実測値 31
5.1125 M+H+、計算値 315.1134
(C20H15N2O2) (5) 紫外線吸収スペクトル (DMSO中):λmax 280nm(ε7500)、
349nm(7000)(6) 赤外線吸収スペクトル
(KBr) νmax 3326、3214、1700、1539、1
241、1207、743 cm-1 (7) 1H−NMR(重DMSO中で測定、500M
Hz)δppm 5.54(s,2H)、6.82
(t,1H,J=7.5Hz)、6.91(t,1H,
J=7.6Hz)、7.01(d,1H,J=7.8H
z)、7.06(t,1H,J=8.2Hz)、7.0
9(t,1H,J=7.6Hz)、7.26(d,1
H,J=8.1Hz)、7.39(d,1H,J=8.
3Hz)、7.39(s,1H)、7.43(d,1
H,J=8.3Hz)、7.50(d,1H,J=2.
4)、11.38(s,NH)、11.64(s,N
H) (8) 13C−NMR(重DMSO中で測定、125M
Hz) δppm 70.6(t)、105.8(s)、10
7.3(s)、111.7(d)、112.0(d)、
112.9(s)、118.7(d)、120.1
(d)、120.3(d)、120.4(d)、12
1.1(d)、121.9(d)、124.7(s)、
125.0(s)、126.1(d)、128.2
(d)、136.0(s)、136.1(s)、15
1.7(s)、174.1(s) (9) 溶解性:DMSOおよびアセトニトリルに可
溶、メタノール、エタノール、アセトン、酢酸エチル、
クロロホルムおよび水には難溶。The physicochemical properties of the compound represented by the formula (II) are shown below. (1) Color of the substance: colorless (2) Molecular weight: 314 (3) Molecular formula: C 20 H 14 N 2 O 2 (4) Mass spectrometry: High-resolution FABMS, actual measurement 31
5.1125 M + H + , calculated 315.1134
(C 20 H 15 N 2 O 2 ) (5) Ultraviolet absorption spectrum (in DMSO): λ max 280 nm (ε7500),
349 nm (7000) (6) Infrared absorption spectrum (KBr) ν max 3326, 3214, 1700, 1539, 1
241, 1207, 743 cm -1 (7) 1 H-NMR (measured in heavy DMSO, 500 M
Hz) δ ppm 5.54 (s, 2H), 6.82
(T, 1H, J = 7.5 Hz), 6.91 (t, 1H,
J = 7.6 Hz), 7.01 (d, 1H, J = 7.8H)
z), 7.06 (t, 1H, J = 8.2 Hz), 7.0
9 (t, 1H, J = 7.6 Hz), 7.26 (d, 1
H, J = 8.1 Hz), 7.39 (d, 1H, J = 8.
3 Hz), 7.39 (s, 1H), 7.43 (d, 1
H, J = 8.3 Hz), 7.50 (d, 1H, J = 2.
4), 11.38 (s, NH), 11.64 (s, N)
H) (8) 13 C-NMR (measured in heavy DMSO, 125 M
Hz) δppm 70.6 (t), 105.8 (s), 10
7.3 (s), 111.7 (d), 112.0 (d),
112.9 (s), 118.7 (d), 120.1
(D), 120.3 (d), 120.4 (d), 12
1.1 (d), 121.9 (d), 124.7 (s),
125.0 (s), 126.1 (d), 128.2
(D), 136.0 (s), 136.1 (s), 15
1.7 (s), 174.1 (s) (9) Solubility: soluble in DMSO and acetonitrile, methanol, ethanol, acetone, ethyl acetate,
Poorly soluble in chloroform and water.
【0017】式(III)で表される化合物の理化学的
性状を以下に示す。 (1) 物質の色:無色 (2) 分子量:311 (3) 分子式:C20H13N3O (4) 質量分析:高分解FABMS 実測値、31
2.1144 M+H+、計算値 312.1137
(C20H14N3O) (5) 紫外線吸収スペクトル (アセトニトリル中):λmax 217nm(ε240
00)、289nm(7900)、310nm(580
0)、389nm(6100) (6) 赤外線吸収スペクトル (KBr) νmax 3414、3224、1601、1446、1
139、735 cm-1(7) 1H−NMR(重ベン
ゼン中で測定、500MHz) δppm 6.86(d,1H,J=8.1Hz)、
6.96(d,1H,J=8.1Hz)、7.00
(s,NH)、7.21(t,1H,J=7.7H
z)、7.26(t,1H,J=7.7Hz)、7.3
9(t,1H,J=7.6Hz)、7.62(d,1
H,J=5.1Hz)、7.83(d,1H,J=8.
1Hz)、8.48(d,1H,J=4.9Hz)、
9.31(d,1H,J=2.9Hz)、9.32
(d,1H,J=7.8Hz)、10.72(s,N
H) (8) 13C−NMR(重DMSO中で測定、125M
Hz) δppm 112.2(d)、112.9(d)、11
4.2(s)、117.8(d)、119.7(d)、
120.0(s)、121.5(d)、121.5
(d)、121.9(d)、122.7(d)、12
7.1(s)、128.5(d)、130.6(s)、
134.9(s)、135.9(s)、136.8
(d)、137.7(d)、138.4(s)、14
1.5(s)、187.2(s) (9) 溶解性:DMSO、アセトニトリル、メタノー
ル、エタノール、アセトン、酢酸エチル、クロロホルム
およびベンゼンに可溶、水には難溶。The physicochemical properties of the compound represented by the formula (III) are shown below. (1) Color of the substance: colorless (2) Molecular weight: 311 (3) Molecular formula: C 20 H 13 N 3 O (4) Mass spectrometry: high resolution FABMS actual measurement, 31
2.1144 M + H + , calculated 312.1137
(C 20 H 14 N 3 O ) (5) UV absorption spectrum (acetonitrile): λ max 217nm (ε240
00), 289 nm (7900), 310 nm (580
0), 389 nm (6100) (6) Infrared absorption spectrum (KBr) ν max 3414, 3224, 1601, 1446, 1
139, 735 cm -1 (7) 1 H-NMR (measured in heavy benzene, 500 MHz) δ ppm 6.86 (d, 1 H, J = 8.1 Hz),
6.96 (d, 1H, J = 8.1 Hz), 7.00
(S, NH), 7.21 (t, 1H, J = 7.7H)
z), 7.26 (t, 1H, J = 7.7 Hz), 7.3
9 (t, 1H, J = 7.6 Hz), 7.62 (d, 1
H, J = 5.1 Hz), 7.83 (d, 1H, J = 8.
1 Hz), 8.48 (d, 1H, J = 4.9 Hz),
9.31 (d, 1H, J = 2.9 Hz), 9.32
(D, 1H, J = 7.8 Hz), 10.72 (s, N
H) (8) 13 C-NMR (measured in heavy DMSO, 125 M
Hz) δ ppm 112.2 (d), 112.9 (d), 11
4.2 (s), 117.8 (d), 119.7 (d),
120.0 (s), 121.5 (d), 121.5
(D), 121.9 (d), 122.7 (d), 12
7.1 (s), 128.5 (d), 130.6 (s),
134.9 (s), 135.9 (s), 136.8
(D), 137.7 (d), 138.4 (s), 14
1.5 (s), 187.2 (s) (9) Solubility: Soluble in DMSO, acetonitrile, methanol, ethanol, acetone, ethyl acetate, chloroform and benzene, poorly soluble in water.
【0018】(2)本発明の化合物の製造 本発明の化合物は、微生物を培地に培養し、培養物中に
本発明の化合物を生成蓄積させ、該培養物から本発明の
化合物を採取することにより製造することができる。こ
こで用いる微生物としては、パラコッカス属に属し、本
発明の化合物を生産する能力を有するものであれば特に
限定されず、パラコッカス sp. F−1547株を
挙げることが出来る。パラコッカス sp. F−15
47株は、自然界から新たに単離した株であり、その細
菌学的性質については以下の通りである。また、前記菌
株の変異株であって、本発明の化合物を生産する能力を
有する菌株も使用することができる。(2) Production of the compound of the present invention The compound of the present invention is obtained by culturing a microorganism in a medium, producing and accumulating the compound of the present invention in a culture, and collecting the compound of the present invention from the culture. Can be manufactured. The microorganism used herein is not particularly limited as long as it belongs to the genus Paracoccus and has the ability to produce the compound of the present invention. Paracoccus sp. The F-1547 strain can be mentioned. Paracoccus sp. F-15
47 strains are strains newly isolated from nature, and their bacteriological properties are as follows. In addition, a mutant strain of the above strain, which has the ability to produce the compound of the present invention, can also be used.
【0019】なお、形態観察は、培地にパラコッカス
sp. F−1547株を植菌し、30℃で24〜48
時間培養したのちに光学顕微鏡及び透過型電子顕微鏡を
用いて行った。培地は、マリンアガー(Bacto M
arine Agar 2216、Difco社製)あ
るいはマリンブロス(Bacto Marine Br
oth 2216、Difco社製)を用いた。The morphological observation was performed by using
sp. F-1547 strain was inoculated at 30 ° C. for 24 to 48 hours.
After culturing for an hour, the measurement was performed using an optical microscope and a transmission electron microscope. The medium was marine agar (Bacto M)
aline Agar 2216, manufactured by Difco) or marine broth (Bacto Marine Br)
oth 2216, manufactured by Difco).
【0020】a.形態 1) 細胞の形および大きさ:短桿〜球菌、1.30〜
0.63×0.90〜0.56μmあるいは0.42〜
0.97μm 2) 細胞の多形性の有無:無し 3) 運動性の有無、鞭毛の着生状態:有り、極毛 4) 胞子の有無:無し 5) グラム染色性:陰性 6) 抗酸性の有無:無し。A. Form 1) Cell shape and size: short rod to cocci, 1.30 to
0.63 × 0.90-0.56 μm or 0.42-
0.97 μm 2) Cell polymorphism: No 3) Motility, flagellar formation: Yes, polar hair 4) Spores: No 5) Gram stain: Negative 6) Acid-fast Presence: None.
【0021】b.各培地における生育状態 1) マリンアガー平板培養:良好に生育、コロニーは
円形、凸円状、全縁、湿光、黄色 2) マリンアガー斜面培養:良好に生育、糸状、黄色 3) マリンブロス培養:良好に生育、均質に濁る 4) マリンブロスゼラチン穿刺培養:液化しない 5) リトマスミルク:変化しない。B. Growth condition in each medium 1) Marine agar plate culture: good growth, colony is circular, convex, whole edge, wet light, yellow 2) Marine agar slope culture: good growth, filamentous, yellow 3) Marine broth culture: good 4) Marine broth gelatin stab culture: does not liquefy 5) Litmus milk: does not change.
【0022】c.生理学的性質 1) 硝酸塩の還元:還元しない 2) MRテスト:陰性 3) VP反応:陰性 4) インドールの生成:生成しない 5) でんぷんの加水分解:分解しない 6) クエン酸の利用:Simmons培地:利用する :Cristensen:利用する 7) 無機窒素源の利用:利用する 8) 色素の生成:有り、黄色(ゼアキサンチン) 9) ウレアーゼ活性:陰性 10) オキシダーゼ活性:陽性 11) カタラーゼ活性:陽性 12) 生育の範囲(温度、pH):温度10〜45
℃、20〜35℃で最も良好に発育、pH5〜10、最
適生育pH範囲 6〜9 13) 酸素に対する態度:好気性 14) OF試験:酸化的にブドウ糖を分解する 15) 糖類からの酸およびガスの生成の有無C. Physiological properties 1) Nitrate reduction: not reduced 2) MR test: negative 3) VP reaction: negative 4) Indole formation: not generated 5) Starch hydrolysis: not degraded 6) Use of citric acid: Simmons medium: Use: Christensen: Use 7) Use of inorganic nitrogen source: Use 8) Pigment generation: Yes, yellow (zeaxanthin) 9) Urease activity: Negative 10) Oxidase activity: Positive 11) Catalase activity: Positive 12) Growth Range (temperature, pH): temperature 10 to 45
℃, 20-35 ° C., best growth, pH 5-10, optimal growth pH range 6-9 13) Attitude to oxygen: aerobic 14) OF test: oxidatively degrade glucose 15) Acids from saccharides and Whether gas is generated
【0023】[0023]
【表1】 16) エスクリンの分解:分解しない 17) アルギニンの分解:分解しない 18) DNAの分解:分解しない 19) 硝酸呼吸能:なし 20) 好塩性:なし、生育塩濃度範囲 0〜15% 21) β−ガラクトシダーゼ:陽性 22) PHBの蓄積:蓄積する 23) GC含量(モル%):65.8 24) イソプレノイドキノン:Q−10。[Table 1] 16) Decomposition of esculin: not decomposed 17) Decomposition of arginine: not decomposed 18) Decomposition of DNA: not decomposed 19) Nitrate respiration: none 20) Halophilicity: none, growth salt concentration range 0-15% 21) β -Galactosidase: positive 22) PHB accumulation: accumulates 23) GC content (mol%): 65.8 24) isoprenoid quinone: Q-10.
【0024】以上の菌学的性質からバージーズ・マニュ
アル・オブ・デターミネイティブ・バクテリオロジーの
分類基準に従って公知の菌種と比較した。本菌株は好気
性グラム陰性桿菌で極鞭毛を有する。ブドウ糖を酸化的
に分解し、オキシダーゼ、カタラーゼが陽性、主たるキ
ノンがQ−10、GC含量65.8mol%という値で
あること、PHBを蓄積することなどからパラコッカス
属に所属すると考えられ、パラコッカス スピーシーズ
(Paracoccus sp.)と同定した。そし
て、この菌株をパラコッカス スピーシーズ(Para
coccus sp.) F−1547とし、平成10
年2月27日付けで工業技術院生命工学工業技術研究所
に受託番号FERM P−16675菌株として寄託し
た。Based on the mycological properties described above, a comparison was made with known bacterial species in accordance with the classification standard of the Virgie's Manual of Deterministic Bacteriology. This strain is an aerobic gram-negative bacillus with polar flagella. It is considered to belong to the genus Paracoccus from the fact that glucose is oxidatively degraded, oxidase and catalase are positive, main quinone is Q-10, GC content is 65.8 mol%, and PHB is accumulated. (Paracoccus sp.). Then, this strain was transformed into Paracoccus species.
coccus sp. ) F-1547
Deposited on February 27, 2012 under the accession number FERM P-16675 at the National Institute of Bioscience and Human-Technology.
【0025】本発明に用いる微生物の培養は、通常の微
生物の培養方法が用いられる。培地としては、資化可能
な炭素源、窒素源、無機物および必要な生育、生産促進
物質を程よく含有する培地であれば合成培地、天然培地
いずれでも使用可能である。炭素源としてはグルコー
ス、澱粉、デキストリン、マンノース、フラクトース、
シュクロース、ラクトース、キシロース、アラビノー
ス、マンニトール、糖蜜などを単独または組み合わせて
用いられる。さらに、必要に応じて炭化水素、アルコー
ル類、有機酸やトリプトファン等のアミノ酸なども用い
られる。窒素源としては塩化アンモニウム、硫酸アンモ
ニウム、硝酸アンモニウム、硝酸ナトリウム、尿素、ペ
プトン、肉エキス、酵母エキス、乾燥酵母、コーン・ス
チープ・リカー、大豆粉、カザミノ酸などが単独または
組み合わせて用いられる。そのほか、必要に応じて食
塩、塩化カリウム、硫酸マグネシウム、炭酸カルシウ
ム、燐酸二水素カリウム、燐酸水素二カリウム、硫酸第
一鉄、塩化カルシウム、硫酸マンガン、硫酸亜鉛などの
無機塩類を加える。さらに使用菌の生育や本発明の化合
物の生産を促進する微量成分を適当に添加することがで
きる。培養法としては、液体培養法が最も適している。
培養温度30〜35℃が適当であり、培養中の培地のP
Hは7〜8に維持することが望ましい。液体培養で通常
3〜5日間培養を行うと、目的物質が培養液中に生成蓄
積される。培養物中の生成量が最大に達した時に培養を
停止する。For culturing the microorganism used in the present invention, a usual culturing method of the microorganism is used. As the medium, any of a synthetic medium and a natural medium can be used as long as the medium contains assimilable carbon sources, nitrogen sources, inorganic substances, and necessary growth and production promoting substances. As a carbon source, glucose, starch, dextrin, mannose, fructose,
Sucrose, lactose, xylose, arabinose, mannitol, molasses and the like are used alone or in combination. Further, if necessary, hydrocarbons, alcohols, organic acids and amino acids such as tryptophan are used. As the nitrogen source, ammonium chloride, ammonium sulfate, ammonium nitrate, sodium nitrate, urea, peptone, meat extract, yeast extract, dried yeast, corn steep liquor, soybean powder, casamino acid and the like are used alone or in combination. In addition, if necessary, inorganic salts such as salt, potassium chloride, magnesium sulfate, calcium carbonate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, ferrous sulfate, calcium chloride, manganese sulfate and zinc sulfate are added. Further, a trace component which promotes the growth of the used bacterium and the production of the compound of the present invention can be appropriately added. The most suitable culture method is a liquid culture method.
A cultivation temperature of 30 to 35 ° C. is appropriate, and the P
It is desirable to maintain H at 7-8. When liquid culture is performed for 3 to 5 days, the target substance is produced and accumulated in the culture solution. The culture is stopped when the production in the culture reaches a maximum.
【0026】培養物から本発明の化合物の単離精製は、
微生物代謝生産物をその培養物から単離精製するために
常用される方法に従って行われる。例えば培養物を濾過
や遠心分離により培養瀘液と菌体に分け、菌体を含水メ
タノール、含水エタノールなどで抽出する。ついで、抽
出液と培養瀘液もしくは培養瀘液を酢酸エチル、クロロ
ホルムなどで抽出した抽出液とを合わせて濃縮し、シリ
カゲルによるカラムクロマトグラフィー、ゲル濾過、高
速液体クロマトグラフィーなどにより、本発明の化合物
を得る。The isolation and purification of the compound of the present invention from the culture
It is performed according to a method commonly used for isolating and purifying a microbial metabolite from its culture. For example, the culture is separated into a culture filtrate and cells by filtration or centrifugation, and the cells are extracted with aqueous methanol, aqueous ethanol, or the like. Subsequently, the extract and the culture filtrate or the extract obtained by extracting the culture filtrate with ethyl acetate, chloroform and the like are combined, concentrated, and subjected to column chromatography on silica gel, gel filtration, high performance liquid chromatography, and the like to give the compound of the present invention. Get.
【0027】なお、培養、精製操作中の本発明の化合物
の動向は、高速液体クロマトグラフィーによる紫外線吸
収を指標として追跡することができるが、多波長検出器
(フォトダイオードアレイディテクター(島津製作所
製、SPD−M6A)を用いUVスペクトルを指標に精
製することが好ましい。The trend of the compound of the present invention during the culturing and purification operations can be traced by using the ultraviolet ray absorption by high performance liquid chromatography as an index, but it can be traced using a multi-wavelength detector (photodiode array detector (manufactured by Shimadzu Corporation). It is preferable to use SPD-M6A) for purification using the UV spectrum as an index.
【0028】(3) 本発明の化合物の用途 本発明の化合物は、理化学的性状の紫外線吸収スペクト
ルの吸収極大波長での吸収能に示されるように紫外線吸
収能が強いので、化粧品或は医薬品などの紫外線吸収成
分として利用することができる。(3) Use of the compound of the present invention The compound of the present invention has a strong ultraviolet absorbing ability as shown by the absorption ability at the absorption maximum wavelength in the ultraviolet absorption spectrum of physicochemical properties, and therefore, it is used in cosmetics or pharmaceuticals. Can be used as an ultraviolet absorbing component.
【0029】以下に本発明を実施例により具体的に説明
する。ただし、本発明はこれら実施例によりその技術的
範囲が限定されるものではない。Hereinafter, the present invention will be described specifically with reference to examples. However, the technical scope of the present invention is not limited by these examples.
【0030】[0030]
【実施例】種菌としてパラコッカス sp. F−15
47株を用いた。該菌株を、300mlのマリンブロス
(ディフコ社製、37g/l)にトリプトファン1gを
加えた液体培地を入れた1l三角フラスコ中で、30
℃、5日間振盪(100r.p.m.)培養した。培養
中、培地のpHは特に制御しなかった。EXAMPLES Paracoccus sp. F-15
Forty-seven strains were used. The strain was placed in a 1 l Erlenmeyer flask containing 300 ml of marine broth (manufactured by Difco, 37 g / l) and 1 g of tryptophan in a liquid medium.
C. for 5 days with shaking (100 rpm). During the culture, the pH of the medium was not particularly controlled.
【0031】このようにして得られた培養液3Lを遠心
分離した。遠心分離によって得られた上澄み液を、酢酸
エチル(3L)で抽出した。また菌体は、エタノール
(100ml)を加え10分間超音波破砕し、遠心分離
によりエタノール抽出液を得た。上澄み液の酢酸エチル
抽出部に菌体のエタノール抽出液を加え、40℃以下で
減圧濃縮した。得られた濃縮液をアセトニトリル−水
(4:6、v/v)を移動相とし、ODSカラム(野村
化学社製、DEVELOSIL ODS−HG−5)を
用いたHPLCで精製し、本発明の化合物(I)および
(II)をそれぞれ1.0mg、2.5mg得た。3 L of the thus obtained culture was centrifuged. The supernatant obtained by centrifugation was extracted with ethyl acetate (3 L). The cells were added with ethanol (100 ml), sonicated for 10 minutes, and centrifuged to obtain an ethanol extract. An ethanol extract of the cells was added to the ethyl acetate extract of the supernatant, and concentrated under reduced pressure at 40 ° C or lower. The obtained concentrated liquid was purified by HPLC using an acetonitrile-water (4: 6, v / v) as a mobile phase and an ODS column (manufactured by Nomura Chemical Co., Ltd., DEVELOSIL ODS-HG-5) to obtain a compound of the present invention. 1.0 mg and 2.5 mg of (I) and (II) were obtained, respectively.
【0032】次いで、化合物(II)が流出した直後の
アセトニトリル−水(6:4、v/v)にステップワイ
ズして、同様にHPLCで精製し、本発明の化合物(I
II)を1.0mg得た。Next, the compound (II) was immediately purified by HPLC after stepwise addition to acetonitrile-water (6: 4, v / v) immediately after the compound (II) was discharged.
1.0 mg of II) was obtained.
【0033】ここで得た化合物(I)、(II)および
(III)は、前記した理化学的性質を示した。The compounds (I), (II) and (III) obtained here exhibited the above-mentioned physicochemical properties.
【0034】なお、この精製工程での条件は以下の通り
であった。 ODSカラムのサイズ:20mmφ×250mm 移動相の流速:14ml/分 化合物(I) 保持時間:16.8分、溶媒:アセトニトリル−水
(4:6、v/v) 化合物(II) 保持時間:24.2分、溶媒:アセトニトリル−水
(4:6、v/v) 化合物(III) 保持時間:41.6分、溶媒:1〜26分はアセトニト
リル−水(4:6、v/v)、26〜41.6分はアセ
トニトリル−水(6:4、v/v)The conditions in this purification step were as follows. ODS column size: 20 mmφ × 250 mm Mobile phase flow rate: 14 ml / min Compound (I) retention time: 16.8 minutes, solvent: acetonitrile-water (4: 6, v / v) Compound (II) retention time: 24 2 minutes, solvent: acetonitrile-water (4: 6, v / v) Compound (III) Retention time: 41.6 minutes, solvent: 1-26 minutes is acetonitrile-water (4: 6, v / v), 26-41.6 minutes for acetonitrile-water (6: 4, v / v)
【0035】[0035]
【発明の効果】本発明は、新規な化合物および該物質の
微生物を用いた製造法を提供する。本発明の化合物は、
脂溶性で、紫外線吸収能が強いので、化粧品或は医薬品
の成分等として利用できる。The present invention provides a novel compound and a method for producing the substance using a microorganism. The compounds of the present invention
Since it is fat-soluble and has a strong ultraviolet absorbing ability, it can be used as a component of cosmetics or pharmaceuticals.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 FI C12P 17/18 C12P 17/18 B //(C12P 17/16 C12R 1:01) (C12P 17/18 C12R 1:01) (72)発明者 西島 美由紀 静岡県清水市袖師町1900番地 株式会社海 洋バイオテクノロジー研究所清水研究所内 (72)発明者 持田 顕一 静岡県清水市袖師町1900番地 株式会社海 洋バイオテクノロジー研究所清水研究所内──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 6 Identification symbol FI C12P 17/18 C12P 17/18 B // (C12P 17/16 C12R 1:01) (C12P 17/18 C12R 1:01) ( 72) Inventor Miyuki Nishijima 1900 Sodesoshi-cho, Shimizu City, Shizuoka Prefecture Inside the Kaiyo Biotechnology Research Institute, Shimizu Research Laboratories (72) Inventor Kenichi Mochida 1900 Sodesoshi-cho, Shimizu City, Shizuoka Prefecture Shimizu Biotechnology Research Institute, Inc. Inside
Claims (4)
載の化合物を生産する能力を有する微生物を培地に培養
し、培養物中に請求項1〜3記載の化合物を生成蓄積さ
せ、該培養物から化合物を採取することを特徴とする請
求項1〜3の内のいずれか1つに記載の化合物の製造
法。4. A microorganism belonging to the genus Paracoccus and capable of producing the compound according to claims 1 to 3 is cultured in a medium, and the compound according to claims 1 to 3 is produced and accumulated in a culture, and the culture is performed. The method for producing a compound according to any one of claims 1 to 3, wherein the compound is collected from the substance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9385598A JPH11269175A (en) | 1998-03-24 | 1998-03-24 | A novel ultraviolet absorbing substance produced by marine bacteria and its production method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9385598A JPH11269175A (en) | 1998-03-24 | 1998-03-24 | A novel ultraviolet absorbing substance produced by marine bacteria and its production method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11269175A true JPH11269175A (en) | 1999-10-05 |
Family
ID=14094045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9385598A Pending JPH11269175A (en) | 1998-03-24 | 1998-03-24 | A novel ultraviolet absorbing substance produced by marine bacteria and its production method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11269175A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008009405A3 (en) * | 2006-07-17 | 2008-03-27 | Syngenta Participations Ag | Novel pyridazine derivatives |
US7419992B2 (en) * | 2001-02-14 | 2008-09-02 | Wisconsin Alumni Research Foundation | Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders |
US8834855B2 (en) | 2005-01-21 | 2014-09-16 | Promar As | Sunscreen compositions comprising carotenoids |
-
1998
- 1998-03-24 JP JP9385598A patent/JPH11269175A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7419992B2 (en) * | 2001-02-14 | 2008-09-02 | Wisconsin Alumni Research Foundation | Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders |
US8834855B2 (en) | 2005-01-21 | 2014-09-16 | Promar As | Sunscreen compositions comprising carotenoids |
WO2008009405A3 (en) * | 2006-07-17 | 2008-03-27 | Syngenta Participations Ag | Novel pyridazine derivatives |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU768773B2 (en) | Process for the preparation of mycophenolic acid and derivatives thereof | |
JPH11269175A (en) | A novel ultraviolet absorbing substance produced by marine bacteria and its production method | |
EP0187049B1 (en) | Micromonospora microorganisms and macrolide antibiotic production therewith | |
JPH0213677B2 (en) | ||
JPH06329576A (en) | New UV absorber | |
JPH0740950B2 (en) | Microbial production of nicotianamine | |
JPH09301970A (en) | Novel macrolactin and method for producing the same | |
JPH05155877A (en) | Novel substances uratimycin A, uratimycin B and their production method | |
JPH104991A (en) | Novel 3-hydroxybutyric acid oligomer and method for producing them | |
JPH08196288A (en) | Method for producing long-chain fatty acid | |
JP4113923B2 (en) | Novel alkaloids urubactin D, E, and methods for producing them | |
JPH10101657A (en) | New alkaloid ulbactin and its production | |
JPH07184668A (en) | Astaxanthin production method | |
JP3858061B2 (en) | Novel chitinase inhibitor and process for producing the same | |
JP2933451B2 (en) | New microorganism and method for producing red pigment by new microorganism | |
JPH02138996A (en) | Production method of canthaxanthin | |
JPH11335210A (en) | Novel algicidal activity selective for dinoflagellate produced by marine bacteria: Active substance and its production method | |
US3979433A (en) | 1,6-Di-O-(2-isocyano-3-methylcrotonyl)-D-mannitol compounds | |
US3986928A (en) | Antibiotic a-32390 and process for preparation thereof | |
JPH09255677A (en) | Novel macrolactins and method for producing the same | |
JP2576883B2 (en) | S-632-bottom 1 and S-632-bottom 2 | |
JPH0547560B2 (en) | ||
AU620595B2 (en) | Process for the preparation of macrolide compounds | |
JPH0482135B2 (en) | ||
CA2095166A1 (en) | Microbiological process for the production of malonyl-7-aminocephalosporanic acid derivatives |